Skip to content
Disclosery

ANTIPODES PARTNERS Ltd: VTR position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on VTR, newest first. How the timeline and the estimate are built.

ANTIPODES PARTNERS Ltd held 592,870 VTR shares at 2026-06-30 per its 13F-HR filed 2026-08-06.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 592,870 shares
    Change vs previous 13F -199,508 shares

    0.96% of the 13F portfolio, value $52,646,856.

    13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 792,378 shares
    Change vs previous 13F -64,594 shares

    1.25% of the 13F portfolio, value $64,800,673.

    13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 856,972 shares
    Change vs previous 13F -243,423 shares

    1.39% of the 13F portfolio, value $66,317,465.

    13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 1,100,395 shares
    Change vs previous 13F -435,646 shares

    1.73% of the 13F portfolio, value $77,022,456.

    13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2025-06-30
    13F 1,536,041 shares
    Change vs previous 13F +69,581 shares

    3.01% of the 13F portfolio, value $97,008,390.

    13F-HR 0002005403-25-000004 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2025-03-31
    13F 1,466,460 shares
    Change vs previous 13F -17,126 shares

    3.16% of the 13F portfolio, value $100,841,880.

    13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2024-12-31
    13F 1,483,586 shares
    Change vs previous 13F +33,670 shares

    3.04% of the 13F portfolio, value $87,375,435.

    13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2024-09-30
    13F 1,449,916 shares
    Change vs previous 13F not available

    3.22% of the 13F portfolio, value $92,989,815.

    13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).